T1	Participants 753 823	Adults with acute leukemia undergoing remission induction chemotherapy
T2	Participants 824 943	randomly were assigned to receive antifungal prophylaxis with AMB (0.5 mg/kg three times weekly) or FLU (400 mg daily).
T3	Participants 1299 1326	36 patients assigned to AMB
T4	Participants 1387 1414	41 patients assigned to FLU
